Healthcare Infection Control Practices Advisory Committee (HICPAC), 17996-17997 [2017-07594]
Download as PDF
17996
Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Conducting Public Health Research in
South Africa; GH17–004, Conducting
Public Health Research Activities in
Egypt.
Summary: This publication corrects a
notice that was published in the Federal
Register on April 4, 2017, Volume 82,
Number 63, page 16403. The meeting
announcement, meeting date, and
matters for discussion should read as
follows:
The meeting announced below
concerns the Centers for Disease Control
and Prevention (CDC) initial review of
applications in response to Funding
Opportunity Announcements GH17–
002, Program Development and
Research to Establish and Evaluate
Innovative and Emerging Best Practices
in Clinical and Community Services
through the President’s Emergency Plan
for AIDS Relief (PEPFAR); and GH17–
003, Conducting Public Health Research
in South Africa.
Time and Date: 9:00 a.m.–2:00 p.m.,
EDT, April 25, 2017, Panel A (Closed).
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Program Development and Research to
Establish and Evaluate Innovative and
Emerging Best Practices in Clinical and
Community Services through the
President’s Emergency Plan for AIDS
Relief (PEPFAR)’’, FOA GH17–002; and
‘‘Conducting Public Health Research in
South Africa’’, FOA GH17–003.
For Further Information Contact:
Hylan Shoob, Scientific Review Officer,
Center for Global Health (CGH) Science
Office, CGH, CDC, 1600 Clifton Road
NE., Mailstop D–69, Atlanta, Georgia
30033, Telephone: (404) 639–4796,
HSHOOB@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–07595 Filed 4–13–17; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
16:21 Apr 13, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Health Resources and Services
Administration
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) and the
Health Resources and Services
Administration (HRSA) announce the
following committee meeting.
Times and Dates: 8:30 a.m.–5:00 p.m.,
EDT, May 10, 2017; 8:30 a.m.–3:00 p.m.,
EDT, May 11, 2017.
Place: CDC Corporate Square,
Building 8, Conference Room 1–ABC, 8
Corporate Boulevard, Atlanta, Georgia
30329, Telephone: (404) 639–8317. The
meeting is also accessible by
teleconference. Toll-free number 1–877–
603–4228, Participant code: 42598858.
Status: Open to the public, limited
only by the space available. The meeting
room will accommodate approximately
100 people. Persons who desire to make
an oral statement, may request it at the
time of the public comment period on
May 10, 2017 at 4:30 p.m., EDT. Public
participation and ability to comment
will be limited to space and time as it
permits.
Purpose: This committee is charged
with advising the Director, CDC and the
Administrator, HRSA, regarding
activities related to prevention and
control of HIV/AIDS, Viral Hepatitis and
other STDs, the support of health care
services to persons living with HIV/
AIDS, and education of health
professionals and the public about HIV/
AIDS, Viral Hepatitis and other STDs.
Matters for Discussion: Agenda items
include the following topics: (1) HIV
transmission risk in the context of viral
suppression and antiretroviral therapy
(ART) use; (2) Update on Pre-Exposure
Prophylaxis (PrEP) utilization; (3)
Vulnerable youth at risk for HIV, STDs,
hepatitis, substance use and other
health outcomes; (4) Eliminating
hepatitis B and hepatitis C as public
health threats in the United States—
Setting Goals and Taking Action; and (5)
Updates from Workgroups. Agenda
items are subject to change as priorities
dictate.
Contact Person for More Information:
Margie Scott-Cseh, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., Mailstop E–07, Atlanta,
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Georgia 30329, telephone (404) 639–
8317; Email: zkr7@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–07593 Filed 4–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID) announces
a meeting of the aforementioned
committee:
Time and Date: 1:00 p.m.–2:30 p.m.,
EDT, May 5, 2017.
Place: This meeting will be accessible
by teleconference. Toll-free +1 (888)
469–1070, Participant Code: 3132529.
Status: Open to the public limited
only by the availability of 200 telephone
ports. To register for this call, please go
to www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include a follow-up discussion on
the Draft Recommendation Update for
Chlorhexidine Impregnated Dressings.
Call materials will be made available to
the public no later than 2 business days
E:\FR\FM\14APN1.SGM
14APN1
Federal Register / Vol. 82, No. 71 / Friday, April 14, 2017 / Notices
before the call. If CDC is unable to post
the background material on the HICPAC
site prior to the meeting, the background
material will be posted on HICPAC’s
Web site after the meeting. Background
material is available at https://
www.cdc.gov/hicpac.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Erin Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE., Mailstop
A–31, Atlanta, Georgia 30333; Email:
HICPAC@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–07594 Filed 4–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–1561/1561A,
CMS–370 and CMS–377, CMS–10488, and
CMS–10393]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:21 Apr 13, 2017
Jkt 241001
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
June 13, 2017.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork
ReductionActof1995/PRA-Listing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–1561/1561A Health Insurance
Benefit Agreement
CMS–370 and CMS–377 ASC Forms
for Medicare Program Certification
CMS–10488 Consumer Experience
Survey Data Collection
CMS–10393 Beneficiary and Family
Centered Data Collection
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
17997
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Health
Insurance Benefit Agreement; Use:
Applicants to the Medicare program are
required to agree to provide services in
accordance with federal requirements.
The CMS–1561/1561A is essential in
that is allows us to ensure that
applicants are in compliance with the
requirements. Applicants will be
required to sign the completed form and
provide operational information to us to
assure that they continue to meet the
requirements after approval. Form
Number: CMS–1561/1561A (OMB
control number: 0938–0832); Frequency:
Yearly; Affected Public: Private sector—
(Business or other for-profits and Notfor-profit institutions); Number of
Respondents: 2,400; Total Annual
Responses: 2,400; Total Annual Hours:
400. (For policy questions regarding this
collection contact Shonte Carter at 410–
786–3532).
2. Type of Information Collection
Request: Extension of a currently
approved collection; Titles of
Information Collection: ASC Forms for
Medicare Program Certification; Use:
The CMS–370 is used to establish
eligibility for payment. This agreement,
upon submission by the ambulatory
surgical center (ASC) and acceptance for
filing by the Secretary of Health &
Human Services, shall be binding on
both the ASC and the Secretary. The
agreement may be terminated by either
party in accordance with regulations. In
the event of termination, payment will
not be available for ASC services
furnished on or after the effective date
of termination.
The Request for Certification or
Update of Certification Information in
the Medicare Program Form (CMS–377)
E:\FR\FM\14APN1.SGM
14APN1
Agencies
[Federal Register Volume 82, Number 71 (Friday, April 14, 2017)]
[Notices]
[Pages 17996-17997]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID) announces a meeting of the aforementioned committee:
Time and Date: 1:00 p.m.-2:30 p.m., EDT, May 5, 2017.
Place: This meeting will be accessible by teleconference. Toll-free
+1 (888) 469-1070, Participant Code: 3132529.
Status: Open to the public limited only by the availability of 200
telephone ports. To register for this call, please go to www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion, the
Director, National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary, Health and Human Services
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include a follow-up
discussion on the Draft Recommendation Update for Chlorhexidine
Impregnated Dressings. Call materials will be made available to the
public no later than 2 business days
[[Page 17997]]
before the call. If CDC is unable to post the background material on
the HICPAC site prior to the meeting, the background material will be
posted on HICPAC's Web site after the meeting. Background material is
available at https://www.cdc.gov/hicpac.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.A., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE., Mailstop A-31, Atlanta, Georgia 30333; Email: HICPAC@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-07594 Filed 4-13-17; 8:45 am]
BILLING CODE 4163-18-P